Literature DB >> 32502332

Prevalence, hospital admissions and costs of child chronic conditions: A population-based study.

Jane Bell1, Raghu Lingam2, Claire E Wakefield3,4, Joanna E Fardell3,4, Justin Zeltzer1, Nan Hu2, Sue Woolfenden2,5, Emily Callander6, Glenn M Marshall3,4, Natasha Nassar1.   

Abstract

AIM: To determine population-based prevalence, hospital use and costs for children admitted to hospital with chronic conditions.
METHODS: We used hospital admissions data for children aged <16 years, 2002-2013 in New South Wales, Australia.
RESULTS: Of all admissions, 35% (n = 692 514) included a diagnosis of a chronic condition. In 2013, prevalence was 25.1 per 1000 children. Children with greater socio-economic disadvantage or living in regional and remote areas had lower prevalence, but a higher proportion of emergency admissions. Prevalence rates were highest for respiratory and neurological conditions (9.4, 7.4 per 1000, respectively). Mental health conditions were most common in older children. Admissions involving chronic conditions had longer length of stay (3.0 vs. 1.6 days), consumed more bed-days (50% of total) and involved 43% of total hospital costs.
CONCLUSION: Differences in prevalence and use of hospital services suggest inequities in access and need for more appropriate and equitable models of care.
© 2020 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).

Entities:  

Keywords:  Australia; children; chronic condition; hospital admission; prevalence

Mesh:

Year:  2020        PMID: 32502332     DOI: 10.1111/jpc.14932

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  2 in total

1.  Healthcare-associated viral respiratory infections in paediatric intensive care unit settings: More than just a sneeze.

Authors:  Kelly Feldman; Wendi Gornick; Beth Huff; Jasjit Singh
Journal:  Infect Prev Pract       Date:  2022-07-16

2.  School academic performance of children hospitalised with a chronic condition.

Authors:  Nan Hu; Joanna Fardell; Claire E Wakefield; Glenn M Marshall; Jane C Bell; Natasha Nassar; Raghu Lingam
Journal:  Arch Dis Child       Date:  2021-09-02       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.